Khaled Farid

596 total citations
38 papers, 411 citations indexed

About

Khaled Farid is a scholar working on Hepatology, Epidemiology and Cancer Research. According to data from OpenAlex, Khaled Farid has authored 38 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Hepatology, 29 papers in Epidemiology and 5 papers in Cancer Research. Recurrent topics in Khaled Farid's work include Liver Disease Diagnosis and Treatment (28 papers), Hepatocellular Carcinoma Treatment and Prognosis (19 papers) and Hepatitis C virus research (18 papers). Khaled Farid is often cited by papers focused on Liver Disease Diagnosis and Treatment (28 papers), Hepatocellular Carcinoma Treatment and Prognosis (19 papers) and Hepatitis C virus research (18 papers). Khaled Farid collaborates with scholars based in Egypt, Saudi Arabia and Iran. Khaled Farid's co-authors include Mohamed M. Omran, Abdelfattah M. Attallah, Ahmed A. Attallah, Mohamed El‐Far, Ibrahim El‐Dosoky, Yehia Shaker, Mahmoud El‐Bendary, Fathy El‐Taweel, Ashraf A. Tabll and Faten Zahran and has published in prestigious journals such as British Journal of Cancer, Clinica Chimica Acta and American Journal of Tropical Medicine and Hygiene.

In The Last Decade

Khaled Farid

35 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Khaled Farid Egypt 13 257 256 73 71 53 38 411
Futoshi Kanke Japan 6 234 0.9× 200 0.8× 136 1.9× 95 1.3× 54 1.0× 9 396
Stéphanie Pascarella Switzerland 9 236 0.9× 219 0.9× 94 1.3× 20 0.3× 38 0.7× 13 356
Marcy Clayton United States 9 113 0.4× 200 0.8× 197 2.7× 74 1.0× 61 1.2× 11 434
Sun Woong Kim South Korea 11 129 0.5× 137 0.5× 36 0.5× 16 0.2× 50 0.9× 24 304
Hiroaki Nagano Japan 11 188 0.7× 114 0.4× 56 0.8× 33 0.5× 106 2.0× 41 374
Shiyong Lin China 9 103 0.4× 72 0.3× 79 1.1× 48 0.7× 75 1.4× 14 316
Kentaroh Yamamoto Japan 7 233 0.9× 123 0.5× 69 0.9× 88 1.2× 80 1.5× 12 389
Katrin Böttcher Germany 8 158 0.6× 181 0.7× 94 1.3× 32 0.5× 31 0.6× 17 382
Alessia Brenna Italy 4 102 0.4× 91 0.4× 132 1.8× 126 1.8× 51 1.0× 5 364
Hasan Özkan Türkiye 11 97 0.4× 110 0.4× 54 0.7× 32 0.5× 88 1.7× 29 299

Countries citing papers authored by Khaled Farid

Since Specialization
Citations

This map shows the geographic impact of Khaled Farid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khaled Farid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khaled Farid more than expected).

Fields of papers citing papers by Khaled Farid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Khaled Farid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khaled Farid. The network helps show where Khaled Farid may publish in the future.

Co-authorship network of co-authors of Khaled Farid

This figure shows the co-authorship network connecting the top 25 collaborators of Khaled Farid. A scholar is included among the top collaborators of Khaled Farid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Khaled Farid. Khaled Farid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Omran, Mohamed M., Khaled Farid, Ashraf A. Tabll, et al.. (2023). Biomarkers for Hepatocellular Carcinoma: From Origin to Clinical Diagnosis. Biomedicines. 11(7). 1852–1852. 25 indexed citations
3.
Omran, Mohamed M., et al.. (2019). A combination of α-fetoprotein, midkine, thioredoxin and a metabolite for predicting hepatocellular carcinoma. Annals of Hepatology. 19(2). 179–185. 18 indexed citations
4.
Attallah, Abdelfattah M., Mohamed El‐Far, Mohamed F. Ghaly, et al.. (2017). Circulating levels of collagen III and MMP-1 in patients with chronic hepatitis C co-infected with hepatitis B virus. British Journal of Biomedical Science. 74(2). 95–100. 3 indexed citations
5.
El‐Far, Mohamed, et al.. (2017). Combined use of nuclear phosphoprotein c-Myc and cellular phosphoprotein p53 for hepatocellular carcinoma detection in high-risk chronic hepatitis C patients. British Journal of Biomedical Science. 74(4). 170–175. 9 indexed citations
6.
Attallah, Abdelfattah M., Mohamed El‐Far, Mohamed M. Omran, et al.. (2016). Levels ofSchistosoma mansoniCirculating Antigen in Chronic Hepatitis C Patients with Different Stages of Liver Fibrosis. Journal of Immunoassay and Immunochemistry. 37(3). 316–330. 1 indexed citations
7.
Attallah, Abdelfattah M., et al.. (2016). Simplified HCC-ART score for highly sensitive detection of small-sized and early-stage hepatocellular carcinoma in the widely used Okuda, CLIP, and BCLC staging systems. International Journal of Clinical Oncology. 22(2). 332–339. 11 indexed citations
8.
Attallah, Abdelfattah M., et al.. (2016). GPC-HCC model: a combination of glybican-3 with other routine parameters improves the diagnostic efficacy in hepatocellular carcinoma. Tumor Biology. 37(9). 12571–12577. 17 indexed citations
9.
Attallah, Abdelfattah M., Mohamed El‐Far, Faten Zahran, et al.. (2016). Interferon-gamma is associated with hepatic dysfunction in fibrosis, cirrhosis, and hepatocellular carcinoma. Journal of Immunoassay and Immunochemistry. 37(6). 597–610. 24 indexed citations
10.
Attallah, Abdelfattah M., Mohamed El‐Far, Mohamed M. Omran, et al.. (2015). A simple diagnostic index comprising epithelial membrane antigen and fibronectin for hepatocellular carcinoma. Annals of Hepatology. 14(6). 869–880. 25 indexed citations
11.
12.
Attallah, Abdelfattah M., et al.. (2015). Fibro-check: a combination of direct and indirect markers for liver fibrosis staging in chronic hepatitis C patients. Annals of Hepatology. 14(2). 225–233. 22 indexed citations
13.
Attallah, Abdelfattah M., Mohamed M. Omran, Khaled Farid, et al.. (2013). Diagnostic value of fibronectin discriminant score for predicting liver fibrosis stages in chronic hepatitis C virus patients. Annals of Hepatology. 12(1). 44–53. 29 indexed citations
14.
Attallah, Abdelfattah M., et al.. (2013). A rapid, low-cost quantitative diagnostic method for hepatitis C virus infection using capillary zone electrophoresis. European Journal of Clinical Microbiology & Infectious Diseases. 33(3). 439–452. 4 indexed citations
15.
Attallah, Abdelfattah M., Mohamed M. Omran, Ahmed A. Attallah, et al.. (2013). HCC-ART score, a simple, highly sensitive and specific test for early diagnosis of hepatocellular carcinoma: a large-scale, multicentre study. British Journal of Cancer. 109(6). 1657–1665. 32 indexed citations
16.
Attallah, Abdelfattah M., et al.. (2012). Development of a novel score for liver fibrosis staging and comparison with eight simple laboratory scores in large numbers of HCV-monoinfected patients. Clinica Chimica Acta. 413(21-22). 1725–1730. 18 indexed citations
17.
Attallah, Abdelfattah M., Mohamed M. Omran, Wesam A. Nasif, et al.. (2012). Diagnostic Performances of Hepatitis C Virus-NS4 Antigen in Patients with Different Liver Pathologies. Archives of Medical Research. 43(7). 555–562. 9 indexed citations
18.
Omran, Mohamed M., et al.. (2011). Fibro-α score as a simple and useful non-invasive test for predicting significant liver fibrosis in chronic hepatitis C patients. Arab Journal of Gastroenterology. 12(2). 74–79. 21 indexed citations
19.
Attallah, Abdelfattah M., et al.. (2011). Evaluation of cytokeratin-1 in the diagnosis of hepatocellular carcinoma. Clinica Chimica Acta. 412(23-24). 2310–2315. 23 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Futoshi Kanke Breakdown of academic impact, for papers by Stéphanie Pascarella Breakdown of academic impact, for papers by Marcy Clayton Breakdown of academic impact, for papers by Sun Woong Kim Breakdown of academic impact, for papers by Hiroaki Nagano Breakdown of academic impact, for papers by Shiyong Lin Breakdown of academic impact, for papers by Kentaroh Yamamoto Breakdown of academic impact, for papers by Katrin Böttcher Breakdown of academic impact, for papers by Alessia Brenna Breakdown of academic impact, for papers by Hasan Özkan
Rankless by CCL
2026